Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes

This study is testing whether a combination of two drugs — cilostazol and ginkgo extract — can help protect or improve cognitive function (thinking and memory) in older adults with type 2 diabetes who are showing early signs of mild cognitive decline. **You may be eligible if...** - You are 60 or older - You have been diagnosed with type 2 diabetes - Your cognitive score (MMSE) is between 24 and 28 (mild decline, but not dementia) **You may NOT be eligible if...** - You have type 1 diabetes, diabetic ketoacidosis, or diabetic coma - Your blood sugar is very poorly controlled (HbA1c above 10%) - Your MMSE score is below 24 (more severe cognitive impairment) - You have been diagnosed with dementia (e.g., Alzheimer's disease) - You need antiplatelet or anticoagulant medications other than the study drugs - You have untreated thyroid disease, severe depression, or severe infection Talk to your doctor to see if this trial is right for you.